FI51765C - A process for the preparation of solid pharmaceutical products having controlled resorption. - Google Patents

A process for the preparation of solid pharmaceutical products having controlled resorption.

Info

Publication number
FI51765C
FI51765C FI174370A FI174370A FI51765C FI 51765 C FI51765 C FI 51765C FI 174370 A FI174370 A FI 174370A FI 174370 A FI174370 A FI 174370A FI 51765 C FI51765 C FI 51765C
Authority
FI
Finland
Prior art keywords
preparation
solid pharmaceutical
pharmaceutical products
controlled resorption
resorption
Prior art date
Application number
FI174370A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI51765B (en
Inventor
Gregor Groppenbaecher
Guenter Ranft
Peter Rieckmann
Werner Rothe
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI51765B publication Critical patent/FI51765B/fi
Application granted granted Critical
Publication of FI51765C publication Critical patent/FI51765C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI174370A 1969-06-24 1970-06-22 A process for the preparation of solid pharmaceutical products having controlled resorption. FI51765C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691931910 DE1931910B2 (en) 1969-06-24 1969-06-24 Process for the production of solid, controllably absorbable pharmaceutical preparations of poorly soluble active ingredients

Publications (2)

Publication Number Publication Date
FI51765B FI51765B (en) 1976-12-31
FI51765C true FI51765C (en) 1977-04-12

Family

ID=5737829

Family Applications (1)

Application Number Title Priority Date Filing Date
FI174370A FI51765C (en) 1969-06-24 1970-06-22 A process for the preparation of solid pharmaceutical products having controlled resorption.

Country Status (10)

Country Link
JP (1) JPS50888B1 (en)
AT (1) AT299452B (en)
DE (1) DE1931910B2 (en)
DK (1) DK125230B (en)
FI (1) FI51765C (en)
FR (1) FR2053007A1 (en)
LU (1) LU61171A1 (en)
NL (1) NL167322C (en)
NO (1) NO131864C (en)
SE (1) SE380729B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2403080A1 (en) * 1977-09-15 1979-04-13 Heyden Chem Fab Slow-release nitro:furantoin compsn. useful as urinary antiseptic - comprises three types of granulate with different solubilities
FR2407720A1 (en) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Oral sustained-action capsule formulations - of drug and excipient which swells in contact with digestive juices
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS61135913U (en) * 1985-02-12 1986-08-23
JP2964195B2 (en) * 1992-04-28 1999-10-18 エスエス製薬株式会社 Piroxicam tablets and method for producing the same
AR016827A1 (en) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL TABLET
AR017512A1 (en) 1997-08-22 2001-09-12 Smithkline Beecham Corp TABLETS OF QUICKLY DISPOSABLE METILCELLULOSE FOR ORAL ROUTE ADMINISTRATION AND PROCEDURE TO PREPARE THEM

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068863B (en) * 1954-03-25 1959-11-12
NL108838C (en) * 1956-03-27

Also Published As

Publication number Publication date
NO131864B (en) 1975-05-12
JPS50888B1 (en) 1975-01-13
FR2053007B1 (en) 1974-08-30
SE380729B (en) 1975-11-17
DE1931910A1 (en) 1971-01-07
FI51765B (en) 1976-12-31
LU61171A1 (en) 1970-08-26
DE1931910B2 (en) 1974-11-28
NL167322C (en) 1981-12-16
DK125230B (en) 1973-01-22
AT299452B (en) 1972-06-26
NL7009172A (en) 1970-12-29
FR2053007A1 (en) 1971-04-16
NO131864C (en) 1975-08-20

Similar Documents

Publication Publication Date Title
DK125207B (en) Process for the preparation of dispersion-enhanced zirconium products.
FI51714C (en) Process for the preparation of isomaltitol.
FI50631C (en) Process for the preparation of embossing derivatives.
OA04511A (en) Process for the preparation of 3-hydroxycephalosporins.
BE808733A (en) PROCESS FOR THE PREPARATION OF CYCLOHEXANE-DIONES-1,3
BE756725A (en) PROCESS FOR THE PREPARATION OF 3,3,3-TRIFLUOROPROPYLMETHYLPOLYSILOXANES
DK136311B (en) Analogous process for the preparation of vitamin A acid amides.
FI51765C (en) A process for the preparation of solid pharmaceutical products having controlled resorption.
FI50334C (en) Process for the preparation of 1-hydroxy-2-pyridones.
BE751321A (en) PROCESS FOR THE PREPARATION OF MATERIALS BASED ON
NL179045C (en) PROCESS FOR THE PREPARATION OF CYCLOPROPAN DERIVATIVES.
FI52216C (en) Process for the preparation of gamma-piperidinobutyrophenone derivatives.
RO71305A (en) PROCESS FOR THE PREPARATION OF D-HALO-6-METHYL-2,8-CYANO- (CARBOXAMIDO) -GEROLINE
NL156157B (en) PROCESS FOR THE PREPARATION OF HARDABLE RESIN PRODUCTS.
RO69492A2 (en) PROCESS FOR THE PREPARATION OF PERCENT-METIL-MERCAPTAN
YU33583B (en) Process for the manufacture of hardened products
SE7602150L (en) INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 4A-ARYL-TRANS-DEKAHYDROISOKINOLINE
FI52096C (en) Process for the preparation of analgesically active 2,3-dihydrotiazolo (3.2.a) pyrimidin-5-ones
CH553216A (en) PROCESS FOR THE PREPARATION OF CETENIMINEPENICILLINS.
BE763173A (en) PROCESS FOR THE PREPARATION OF 6-ALCOXY-5,6-DIHYDRO-4H-PYRANNES
CH556330A (en) PROCESS FOR THE PREPARATION OF CYCLOHEXADIENYLAMIDOALCOYLPHENYLSULFONYLUREES.
OA04432A (en) Process for the preparation of 3-amino-pyrazolones- (5).
NL153865B (en) PROCESS FOR THE CONTINUOUS PREPARATION OF CAPROLACTAM.
ZA731290B (en) Process for the manufacture of virtually bloom-free gypsum products
NL167672B (en) PROCESS FOR THE CONTINUOUS PREPARATION OF MONOCHLORAL ALBES.